Tahan, Veysel

Publishing since 1998 (Senior)

Has published 52 publications in 13 years

Number of publications published per year by Tahan, Veysel. (Source : PubMed)

Distribution of publications types for Tahan, Veysel. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Ozdemir FT, Tiftikci A, Sancak S, Eren F, Tahan V, Akın H, Gündüz F, Kedrah AE, Ustündağ Y, Avşar E, Tözün N, Ozdoğan O. The Prevalence of the Mutation in Codon 249 of the P53 Gene in Patients with Hepatocellular Carcinoma (HCC) in Turkey.  Journal of gastrointestinal cancer  2010  
•  Tahan V, Ozaras R, Karaca C, Uraz S, Eren F, Danalioglu A, Avsar E, Turkoglu S, Midilli K, Tabak F, Ozturk R, Mert A, Senturk H, Tozun N. Is HCV genotyping cost-effective even when the prevalences of genotypes 2 and 3 are low?  Hepatogastroenterology  2009;56;94-95  
•  Tabak F, Gunduz F, Tahan V, Tabak O, Ozaras R. Sertraline hepatotoxicity: report of a case and review of the literature.  Dig. Dis. Sci.  2009;54;7  
•  Canbakan B, Akin H, Tahan G, Tarcin O, Eren F, Atug O, Tahan V, Imeryuz N, Yapicier O, Avsar E, Tozun N. The effects of pegylated interferon alpha 2b on bile-duct ligation induced liver fibrosis in rats.  Ann Hepatol  2009;8;3  
•  Ozaras R, Tahan V. Acute hepatitis C: prevention and treatment.  Expert Rev Anti Infect Ther  2009;7;3  
•  Ozaras R, Ipekci S, Kumbasar H, Aybar Y, Tahan V, Mert A, Ozturk R, Tabak F. Does the presence of peripheral and intra-abdominal lymphadenopathy predict the etiology of acute hepatitis?  J. Clin. Gastroenterol.  2009;43;2  
•  Atug O, Tahan V, Eren F, Tiftikci A, Imeryuz N, Hamzaoglu HO, Tozun N. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPARgamma) gene in inflammatory bowel disease.  J Gastrointestin Liver Dis  2008;17;4  
•  Ozaras R, Yilmaz M, Mete B, Demirel A, Tahan V. Recognizing acute hepatitis C in hemodialysis patients.  Dig. Dis. Sci.  2008;53;12  
•  Ozaras R, Tabak F, Tahan V, Ozturk R, Akin H, Mert A, Senturk H. Correlation of quantitative assay of HBsAg and HBV DNA levels during chronic HBV treatment.  Dig. Dis. Sci.  2008;53;11  
•  Tahan V, Canbakan B, Balci H, Dane F, Akin H, Can G, Hatemi I, Olgac V, Sonsuz A, Ozbay G, Yurdakul I, Senturk H. Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk.  Hepatogastroenterology  2008;55;85  

[ See timeline ] [ See all publications ]